Global trends in neglected tropical disease control and elimination: Impact on child health

Archives of Disease in Childhood

Volumn 98, Issue 8, 2013, Pages 635-641

  Barry, Meagan A ^a   Simon, Gregory G ^b   Mistry, Neeraj ^b   Hotez, Peter J ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SABIN VACCINE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTIPARASITIC AGENT; AZITHROMYCIN; BENZIMIDAZOLE; CHLORPHENOTANE; DIETHYLCARBAMAZINE; IVERMECTIN; MEBENDAZOLE; ORAL POLIOMYELITIS VACCINE; PRAZIQUANTEL;

ARTICLE; ASCARIASIS; ASCARIS; ASCARIS LUMBRICOIDES; BRUGIA TIMORI; CHEMOTHERAPY; CHLAMYDIA TRACHOMATIS; COMMUNITY CARE; DISEASE CONTROL; DISEASE ELIMINATION; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; FEMALE GENITAL SYSTEM; GROUPS BY AGE; HEALTH PROGRAM; HELMINTHIASIS; HOOKWORM; HOOKWORM INFECTION; HUMAN; INFECTION; INFECTION RISK; LYMPHATIC FILARIASIS; MORBIDITY; NECATOR AMERICANUS; NONHUMAN; ONCHOCERCA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PRIORITY JOURNAL; SCHISTOSOMA; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TRACHOMA; TRICHURIASIS; TRICHURIS TRICHIURA; TROPICAL DISEASE; WORLD HEALTH ORGANIZATION; WUCHERERIA BANCROFTI;

PARASITOLOGY; TROPICAL INF DIS; TROPICAL PAEDIATRICS;

CHILD; CHILD WELFARE; COMMUNICABLE DISEASE CONTROL; HUMANS; NEGLECTED DISEASES; TROPICAL MEDICINE; WORLD HEALTH;

EID: 84881251631     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2012-302338     Document Type: Article

References (83)

1. UN. Millennium Development Goals 2010 [updated 2010; cited 17 February 2013]. http://www.un.org/millenniumgoals/
2. Hotez P, Ottesen E, Fenwick A, et al. The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination. Adv Exp Med Biol 2006;582:23-33.
3. Hotez P. A handful of 'antipoverty' vaccines exist for neglected diseases, but the world's poorest billion people need more. Health Aff (Millwood) 2011;30:1080-7.
4. Shenoy RK, Bockarie MJ. Lymphatic filariasis in children: clinical features, infection burdens and future prospects for elimination. Parasitology 2011;138:1559-68.
5. Witt C, Ottesen EA. Lymphatic filariasis: an infection of childhood. Trop Med Int Health 2001;6:582-606.
6. Hotez PJ, Brooker S, Bethony JM, et al. Hookworm infection. N Engl J Med 2004;351:799-807.
7. WHO. Guinea-worm disease: countdown to eradication, 2012. http://whqlibdoc.who. int/hq/2012/WHO-HTM-NTD-PCT-2012.2-eng.pdf (accessed 17 February 2013).
8. Molyneux DH, Hotez PJ, Fenwick A. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2005;2:e336.
9. Molyneux DH, Nantulya VM. Linking disease control programmes in rural Africa: a pro-poor strategy to reach Abuja targets and millennium development goals. BMJ 2004;328:1129-32.
10. Raso G, Luginbuhl A, Adjoua CA, et al. Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Cote d'Ivoire. Int J Epidemiol 2004;33:1092-102.
11. McKenzie FE. Polyparasitism. Int J Epidemiol 2005;34:221-2; author reply 22-3.
12. Hotez PJ, Molyneux DH, Fenwick A, et al. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med 2006;3:e102.
13. de Silva NR, Brooker S, Hotez PJ, et al. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol 2003;19:547-51.
14. Anderson RM, May RM. Population dynamics of human helminth infections: control by chemotherapy. Nature 1982;297:557-63.
15. WHO. PCT databank 2013 [updated 2013; cited 8 March 2013]. http://www.who. int/neglected-diseases/preventive-chemotherapy/sch/en/index.html
16. Solomons NW. Pathways to the impairment of human nutritional status by gastrointestinal pathogens. Parasitology 1993;107(Suppl):S19-35.
17. Crompton DW, Nesheim MC. Nutritional impact of intestinal helminthiasis during the human life cycle. Annu Rev Nutr 2002;22:35-59.
18. Brooker S, Clements AC, Hotez PJ, et al. The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren. Malar J 2006;5:99.
19. Hall A, Hewitt G, Tuffrey V, et al. A review and meta-analysis of the impact of intestinal worms on child growth and nutrition. Matern Child Nutr 2008;4(Suppl 1):118-236.
20. Nokes C, Grantham-McGregor SM, Sawyer AW, et al. Parasitic helminth infection and cognitive function in school children. Proc Biol Sci 1992;247:77-81.
21. Kvalsvig JD, Cooppan RM, Connolly KJ. The effects of parasite infections on cognitive processes in children. Ann Trop Med Parasitol 1991;85:551-68.
22. Brooker S, Akhwale W, Pullan R, et al. Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am J Trop Med Hyg 2007;77(6 Suppl):88-98.
23. Fulford AJ, Ouma JH, Kariuki HC, et al. Water contact observations in Kenyan communities endemic for schistosomiasis: methodology and patterns of behaviour. Parasitology 1996;113(Pt 3):223-41.
24. Stothard JR, Sousa-Figueiredo JC, Betson M, et al. Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. Parasitology 2011;138:1593-606.
25. Steinmann P, Keiser J, Bos R, et al. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006;6:411-25.
26. King CH. Parasites and poverty: the case of schistosomiasis. Acta Trop 2010;113:95-104.
27. King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn 2008;4:65-79.
28. Stothard JR, Sousa-Figueiredo JC, Betson M, et al. Schistosomiasis in African infants and preschool children: let them now be treated! Trends Parasitol 2013;29:197-205.
29. Stothard JR, Gabrielli AF. Schistosomiasis in African infants and preschool children: to treat or not to treat? Trends Parasitol 2007;23:83-6.
30. Stothard JR, Sousa-Figueiredo JC, Betson M, et al. Schistosoma mansoni Infections in young children: when are schistosome antigens in urine, eggs in stool and antibodies to eggs first detectable? PLoS Negl Trop Dis 2011;5:e938.
31. Balen J, Stothard JR, Kabatereine NB, et al. Morbidity due to Schistosoma mansoni: an epidemiological assessment of distended abdomen syndrome in Ugandan school children with observations before and 1-year after anthelminthic chemotherapy. Trans R Soc Trop Med Hyg 2006;100:1039-48.
32. Kjetland EF, Leutscher PD, Ndhlovu PD. A review of female genital schistosomiasis. Trends Parasitol 2012;28:58-65.
33. Secor WE. The effects of schistosomiasis on HIV/AIDS infection, progression and transmission. Curr Opin HIV AIDS 2012;7:254-9.
34. Global WHO Alliance for the Elimination of Blinding Trachoma by 2020. Wkly Epidemiol Rec 2012;87:161-8.
35. West SK, Munoz B, Turner VM, et al. The epidemiology of trachoma in central Tanzania. Int J Epidemiol 1991;20:1088-92.
36. Wright HR, Turner A, Taylor HR. Trachoma. Lancet 2008;371:1945-54.
37. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012;96:614-8.
38. Managing morbidity and preventing disability in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement. Wkly Epidemiol Rec 2011;86:581-5.
39. Webber RH. Eradication of Wuchereria bancrofti infection through vector control. Trans R Soc Trop Med Hyg 1979;73:722-4.
40. Greene BM. Modern medicine versus an ancient scourge: progress toward control of onchocerciasis. J Infect Dis 1992;166:15-21.
41. Remme J, Dadzie KY, Rolland A, et al. Ocular onchocerciasis and intensity of infection in the community. I. West African savanna. Trop Med Parasitol 1989;40:340-7.
42. Hotez PJ, Molyneux DH, Fenwick A, et al. Control of neglected tropical diseases. N Engl J Med 2007;357:1018-27.
43. WHO. Sustaining the drive to overcome the global impact of neglected tropical diseases: Second WHO report on neglected tropical diseases, 2013.
44. WHO. Neglected tropical diseases. 2013 [updated 2013 28 February 2013; cited 5 March 2013]. http://www.who.int/neglected-diseases/en/
45. USAID. USAID's NTD Program. 2009 [updated 2009 15 October 2012; cited 5 March 2013]. http://www.neglecteddiseases.gov
46. The END Fund. 2013 [updated 2013; cited 5 March 2013]. http://www.end.org
47. Global Network: Neglected Tropical Diseases. 2012 [updated 2012; cited 5 March 2013]. http://www.globalnetwork.org
48. Fenwick A. New initiatives against Africa's worms. Trans R Soc Trop Med Hyg 2006;100:200-7.
49. SCI. Schistosomiasis Control Initiative 2013 [updated 2013; cited 5 March 2013]. http://www3.imperial.ac.uk/schisto
50. Hotez PJ. Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases. Clin Pharmacol Ther 2009;85:659-64.
51. Soil-transmitted helminthiases: estimates of the number of children needing preventive chemotherapy and number treated, 2009. Wkly Epidemiol Rec 2011;86:257-67.
52. Stephenson LS, Latham MC, Kinoti SN, et al. Improvements in physical fitness of Kenyan schoolboys infected with hookworm, Trichuris trichiura and Ascaris lumbricoides following a single dose of albendazole. Trans R Soc Trop Med Hyg 1990;84:277-82.
53. Stephenson LS, Latham MC, Kurz KM, et al. Treatment with a single dose of albendazole improves growth of Kenyan schoolchildren with hookworm, Trichuris trichiura, and Ascaris lumbricoides infections. Am J Trop Med Hyg 1989;41:78-87.
54. Nokes C, Grantham-McGregor SM, Sawyer AW, et al. Moderate to heavy infections of Trichuris trichiura affect cognitive function in Jamaican school children. Parasitology 1992;104(Pt 3):539-47.
55. Sakti H, Nokes C, Hertanto WS, et al. Evidence for an association between hookworm infection and cognitive function in Indonesian school children. Trop Med Int Health 1999;4:322-34.
56. Miguel EA, Kremer M. Worms: Identifying Impacts on Education and Health in the Presence of Treatment Externalities. Econometrica 2003;72:159-217.
57. WHO. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser 2002;912:1-57.
58. Taylor-Robinson DC, Maayan N, Soares-Weiser K, et al. Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performance. Cochrane Database Syst Rev 2012;7:CD000371.
59. Garner P, Hotez P, Fenwick A, et al. Should Deworming Policies in the Developing World be Reconsidered? : PLOS Medicine; [July 18, 2012; cited 16 February 2013]. http://blogs.plos.org/speakingofmedicine/2012/07/18/should- deworming-policiesin- the-developing-world-be-reconsidered/
60. Smith JL, Brooker S. Impact of hookworm infection and deworming on anaemia in non-pregnant populations: a systematic review. Trop Med Int Health 2010;15:776-95.
61. Anderson RM, Truscott JE, Pullan RL, et al. How effective is school-based deworming for the community-wide control of soil-transmitted helminths? PLoS Negl Trop Dis 2013;7:e2027.
62. Mohammed KA, Haji HJ, Gabrielli AF, et al. Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study. PLoS Negl Trop Dis 2008;2:e171. Global child health
63. Eigege A, Pede E, Miri E, et al. Triple drug administration (TDA), with praziquantel, ivermectin and albendazole, for the prevention of three neglected tropical diseases in Nigeria. Ann Trop Med Parasitol 2008;102:177-9.
64. Na-Bangchang K, Kietinun S, Pawa KK, et al. Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations. Trans R Soc Trop Med Hyg 2006;100:335-45.
65. WHO. Table of Commitments 2012 [updated 2012; cited 17 February 2013]. http:// www.who.int/neglected-diseases/NTD-London-Event-Table-Commitments.pdf
66. Ending the Neglect & Reaching 2020 Goals: Table of Commitments 2012. http://www. unitingtocombatntds.org/downloads/press/ntd-event-table-of- commitments.pdf
67. Conteh L, Engels T, Molyneux DH. Socioeconomic aspects of neglected tropical diseases. Lancet 2010;375:239-47.
68. Sabin Vaccine Institute 2011 Annual Report. Sabin Vaccine Institute 2012 [updated 2012 12 October 2012; cited 19 February 2013]. http://issuu.com/ sabinvaccineinstitute/docs/f-sabin1003-ar2011-single-pages/1
69. From Promises to Progress: The First Annual Report on the London Declaration on NTDs. 2013. http://www.unitingtocombatntds.org/reports/promises- to-progress-EN.pdf
70. WHO. Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation, 2012. http://whqlibdoc.who.int/ hq/2012/ WHO-HTM-NTD-2012.1-eng.pdf
71. Hotez PJ, Fenwick A, Savioli L, et al. Rescuing the bottom billion through control of neglected tropical diseases. Lancet 2009;373:1570-5.
72. Albonico M, Engels D, Savioli L. Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control. Int J Parasitol 2004;34:1205-10.
73. Hotez PJ, Ferris MT. The antipoverty vaccines. Vaccine 2006;24:5787-99.
74. Hotez PJ, Bethony J, Bottazzi ME, et al. New technologies for the control of human hookworm infection. Trends Parasitol 2006;22:327-31.
75. Bethony JM, Simon G, Diemert DJ, et al. Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults. Vaccine 2008;26:2408-17.
76. Diemert DJ, Pinto AG, Freire J, et al. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths. J Allergy Clin Immunol 2012;130:169-76 e6.
77. Hotez P. Enlarging the "Audacious Goal": elimination of the world's high prevalence neglected tropical diseases. Vaccine 2011;29(Suppl 4):D104-10.
78. Hotez PJ, Bethony JM, Diemert DJ, et al. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol 2010;8:814-26.
79. Tamarozzi F, Tendongfor N, Enyong PA, et al. Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis. Parasit Vectors 2012;5:53.
80. Denery JR, Nunes AA, Hixon MS, et al. Metabolomics-based discovery of diagnostic biomarkers for onchocerciasis. PLoS Negl Trop Dis 2010;4.
81. Wichmann D, Poppert S, Von Thien H, et al. Prospective European-wide multicentre study on a blood based real-time PCR for the diagnosis of acute schistosomiasis. BMC Infect Dis 2013;13:55.
82. Coulibaly JT, Knopp S, N'Guessan NA, et al. Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni diagnosis in different settings of Cote d'Ivoire. PLoS Negl Trop Dis 2011;5:e1384.
83. Prichard RK, Basanez MG, Boatin BA, et al. A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis 2012;6:e1549